NAPLES, Fla. and CAMBRIDGE, United Kingdom, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), is pleased to announce the completion of the ...
This innovative approach aims to reduce human error, cut costs, and improve efficiency, positioning Conduit for success across its current and future portfolio. By entering into this agreement with ...
Conduit Pharmaceuticals has partnered with SARBORG Limited to utilize an advanced artificial intelligence and cybernetics platform aimed at improving various drug development processes, such as drug ...
An experiment at Procter & Gamble reveals that artificial intelligence isn't just a tool—it's becoming a teammate that can ...
Cybernetic Bridge Between US And China In AI. For the second time in two years, hundreds of mostly Western public ...
Conduit Pharmaceuticals partners with SARBORG Limited to leverage artificial intelligence and cybernetics for optimizing key drug development processes, including drug repurposing, discovery, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback